Previous Page

 

Bretylium [bre til' ee um]
(Class III, Potassium Channel Blocker)

  • Antiarrhythmic effect due to prolongation of the cardiac action potential and inhibition of norepinephrine reuptake by sympthetic nerves

  • Bretylium infusions are used to treat ventricular fibrillation in emergent circumstances with the aim of control and prevention of recurrence.

  • No longer a first-line agent.

 

Previous Page